mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer. - von Wichert L; Stroh A; Witt M; Wanzel M; Mernberger M; Griewing S; Wündisch T; Pfitzner BM; Teply-Szymanski J; Litmeyer AS; Denkert C; Wagner U; et al. (Cell death & disease, 2026)